AURORA, Ontario, June 11 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP / Pink Sheets: HXBPF) today announced financial results for the third quarter ended April 30, 2010.
HIGHLIGHTS
Announced on February 12, 2010 positive preliminary primary endpoint findings from the ongoing Phase